[Microalbuminuria in @entity6 with moderate XXXX ].

@entity1 @entity2175 @entity8 @entity101 @entity6 @entity28 @entity2316 @entity989 @entity1011
The relation between @entity101 and @entity2316 is complex. @entity8 is probably involved in the elevated blood pressure found in @entity6 @entity1 . In @entity2175 onset @entity6 , @entity1 may also have @entity101 which is associated with @entity28 or essential @entity101 . It has been suggested that in both types of @entity6 , @entity101 enhances the development of @entity2316 . Moreover, an aggressive antihypertensive treatment seems able to reduce rate of @entity8 in insulin-dependent @entity6 @entity1 with patent @entity8 . In this work, @entity1011 clearance and microalbuminuria in 20 @entity6 @entity1 (mostly with @entity2175 -onset- @entity6 ) with known moderate and effectively treated @entity101 were therefore measured and the results were compared with those for 18 normotensive @entity6 @entity1 and 22 controls. Duration of @entity6 was from one to 26 years (mean: 11 years) and duration of @entity101 was from one to 35 years (mean: 10 years). @entity1 and controls had normal serum @entity1011 and proteinuria below 0.1 g/l. Microalbuminuria was measured by immunonephelometric assay using specific antiserum (sensitivity = 1.5 mg/l; intra and interassay coefficients: 6.5% and 8% respectively). The highest value was observed in @entity101 @entity6 @entity1 with @entity989 (group 1). But @entity101 @entity1 without @entity989 (group 2) and normotensive @entity1 also had significantly increased microalbuminuria. In group 1, microalbuminuria was significantly higher than in group 2. The @entity1011 clearance was reduced in groups 1 and 2 versus normotensive @entity6 , but @entity101 @entity1 were older.(ABSTRACT TRUNCATED AT 250 WORDS)
